Both in Pharmaceuticals
USANA Health Sciences vs Fulcrum Therapeutics
Over the past year USNA returned −32.4% and FULC returned −61.9%; their daily moves had a correlation of 0.06.
USNA −32.4% FULC −61.9%Growth of $1, one year, split-adjusted
| Metric | USNA | FULC |
|---|---|---|
| Price | $14.22 | $3.70 |
| Market cap | $262.7M | $282.6M |
| Today | −3.40% | −0.54% |
| 1 month | −3.8% | −3.6% |
| 6 months | −27.2% | −52.3% |
| Year to date | −27.6% | −67.3% |
| 1 year | −31.2% | −59.9% |
| Revenue growth (YoY) | −5.3% | — |
| Gross margin | 78.3% | — |
| Net margin | −9.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | — |
| Net cash | $168.6M | $318.8M |
| Dividend yield | — | — |
| Volatility (60d) | 92.8% | 21.5% |
| Short % of float | 7.1% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).